PT06.5: Dietary Patterns are Associated with Prevalence of Nonalcoholic Fatty Liver Disease in Korean Adults

2016 ◽  
Vol 35 ◽  
pp. S34
Author(s):  
Y.S. Kim ◽  
G.E. Chung ◽  
S.Y. Yang ◽  
J.H. Lim ◽  
J.H. Song ◽  
...  
Nutrition ◽  
2019 ◽  
Vol 62 ◽  
pp. 32-38 ◽  
Author(s):  
Goh Eun Chung ◽  
Jiyoung Youn ◽  
Young Sun Kim ◽  
Jung Eun Lee ◽  
Sun Young Yang ◽  
...  

2019 ◽  
Vol Volume 12 ◽  
pp. 315-324 ◽  
Author(s):  
Davood Soleimani ◽  
Golnaz Ranjbar ◽  
Reza Rezvani ◽  
Ladan Goshayeshi ◽  
Farkhonde Razmpour ◽  
...  

Nutrients ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 2878 ◽  
Author(s):  
Kiarash Riazi ◽  
Maitreyi Raman ◽  
Lorian Taylor ◽  
Mark G. Swain ◽  
Abdel Aziz Shaheen

Nonalcoholic fatty liver disease (NAFLD) is a rising epidemic worldwide and will be the leading cause of cirrhosis, hepatocellular carcinoma, and liver transplant within the next decade. NAFLD is considered as the hepatic manifestation of metabolic syndrome. Behaviors, such as a sedentary lifestyle and consuming a Western diet, have led to substantial challenges in managing NAFLD patients. With no curative pharmaceutical therapies, lifestyle modifications, including dietary changes and exercise, that ultimately lead to weight loss remain the only effective therapy for NAFLD. Multiple diets, including low-carbohydrate, low-fat, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean (MD) diets, have been evaluated. NAFLD patients have shown better outcomes with a modified diet, such as the MD diet, where patients are encouraged to increase the consumption of fruits and vegetables, whole grains, and olive oil. It is increasingly clear that a personalized approach to managing NAFLD patients, based on their preferences and needs, should be implemented. In our review, we cover NAFLD management, with a specific focus on dietary patterns and their components. We emphasize the successful approaches highlighted in recent studies to provide recommendations that health care providers could apply in managing their NAFLD patients.


2016 ◽  
Vol 461 ◽  
pp. 14-18 ◽  
Author(s):  
Ji Sun Nam ◽  
Sehee Jo ◽  
Shinae Kang ◽  
Chul Woo Ahn ◽  
Kyung Rae Kim ◽  
...  

Author(s):  
Yun-Jung Yang ◽  
Taehyen Kim ◽  
Yeon-Pyo Hong

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. Recent experimental studies suggested that phthalates might induce NAFLD. Therefore, this study aimed to investigate the relationship between phthalates metabolites and NAFLD in the human population. This cross-sectional analysis was performed using data from the Korean National Environmental Health Survey II (2012–2014) among Korean adults (n = 5800). NAFLD was diagnosed using the hepatic steatosis index (HSI) in the absence of other causes of chronic liver diseases. Among the participants (mean age 46 years, 47.5% male), the prevalence of NAFLD was associated with urinary levels of mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono-(2-ethyl-5-oxohexyl) phthalate, mono-(2-ethyl-5-carboxypentyl) phthalate, mono-benzyl phthalate (MBzP), and mono-n-butyl phthalate (MnBP) compared to the reference group. In the multivariate model, the odds ratios (ORs), 95% confidence interval (CI) for NAFLD were 1.33 (1.00–1.78) and 1.39 (1.00–1.92) in the 3rd and 4th quartile of MEHHP, respectively. Based on the study findings, high levels of urinary phthalates are associated with the prevalence of NAFLD in Korean adults. Further investigation is required to elucidate the causal relationship.


Sign in / Sign up

Export Citation Format

Share Document